Cevher Ozcan
Section of Cardiology
Assistant Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730

Training

DegreeYearInstitutionArea
MD1991Cukurova University 
Chief Resident1998Inonu UniversityInternal Medicine
Fellowship2003Mayo ClinicCardiovascular Disease Research
Residency2006Medical College of WisconsinInternal Medicine
Fellowship2009Yale UniversityCardiovascular Medicine
Fellowship2011Harvard University (MGH)Clinical Cardiac Electrophysiology

Academic Interests

As an academic cardiac electrophysiologist, Dr. Ozcan's research focuses on the molecular mechanisms of arrhythmias and novel therapeutic strategies for management of the patients with heart rhythm disorders. Her clinical research includes the pharmacological and non-pharmacological treatments of atrial fibrillation (AF), supraventricular and ventricular arrhythmias, implantable cardiac devices and prevention of sudden cardiac death. Her current basic research program focuses on the molecular mechanisms of AF and the novel therapeutic targets for the treatment of AF disease process. As an NIH funded investigator, she works on mitochondrial mechanisms of AF and the role of cellular energetics and metabolism in mechanisms of arrhythmias. Dr. Ozcan's ultimate goal is to develop novel therapies for primary and secondary prevention of AF and other arrhythmias by targeting the molecular mechanisms of the disease.


Clinical Interests

As a clinical cardiac electrophysiologist, Dr. Ozcan's patient care focuses on the treatment of heart rhythm disorders in adults. She provides optimal care to the patients with complex arrhythmias including atrial fibrillation, paroxysmal supraventricular tachyarrhythmias, cardiac conduction disease, syncope and ventricular arrhythmias.


Representative Publications

  1. C. Ozcan,. 2001. Atrial Fibrillation: Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N ENGL J MED 344:1043-1051.
  2. C. Ozcan,. 2002. Sudden cardiac death following atrioventricular node ablation in patients with atrial fibrillation. J Am Coll Cardiol 40:105-110.
  3. C. Ozcan,. 2013. Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning. Am J Physiol Heart Circ Physiol 304:H1192-200.
  4. C. Ozcan,. 2014. Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias. EP Europace 16:1508-1514.
  5. C. Ozcan C,. 2015. LKB1 Knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J Am Heart Assoc 2015;4:e001733.



More Information

For more information about Dr. Cevher Ozcan publications and research collaborations , please click here